Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Most Read

  1. AstraZeneca’s Imfinzi looks to maintenance setting in advanced NSCLC to reverse fortunes
  2. Acticor Biotech to assess ACT017 in Phase I trial
  3. Tenapanor likely to makes waves in IBS-C space
  4. Why are over half of newly-approved cancer drugs failing to deliver?
  5. Anacetrapib failure marks the death of the CETP class of cholesterol-lowering therapies

Latest Content

Tenapanor likely to makes waves in IBS-C space

On 11 October, Ardelyx reported positive results from a second pivotal Phase III trial (T3MPO-2) assessing the efficacy and safety of its lead product, tenapanor, which is under development for treatment of irritable bowel syndrome with constipation.

Latest News

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Go Top